Yahoo Finance

Viral Vector Collaboration, R&D, and Licensing Deals Trends Report 2024 with Directory of 396 Agreements Signed Since 2016

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Viral Vector Collaboration and ...
Yahoo Finance

Viral Vector Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 396 Deals Signed Since 2016 by Company A-Z, Financial terms, Deal Type and Therapy Focus

Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a ...
Yahoo Finance

Viral Vector Collaboration and Licensing Agreements Analysis Report and Directory 2016-2025: Access to Confidential Contract Documents for In-Depth Due Diligence and Benchmarking

Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
GEN

Cobra Biologics and Symbiosis Complete Viral Vector Collaboration

Cobra Biologics, a CDMO focused on viral vector drug substance production, and Symbiosis Pharmaceutical Services, a CMO specializing in the sterile manufacture of injectable viral vector drug products ...
Mena FN

Viral Vector Collaboration And Licensing Agreements Analysis Report And Directory 2016-2025: Access To Confidential Contract Documents For In-Depth Due Diligence And Benchmarking

(MENAFN- GlobeNewsWire - Nasdaq) Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral vector deals entered into by the world's ...